BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7572315)

  • 1. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
    Motoie H; Nakamura T; O'uchi N; Nishikawa H; Kanoh H; Abe T; Kawashima H
    J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction.
    Yoshida Y; Moriya A; Kitamura K; Inazu M; Okimoto N; Okazaki Y; Nakamura T
    J Bone Miner Res; 1998 Jun; 13(6):1011-22. PubMed ID: 9626633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
    Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
    J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats.
    Katsumata T; Nakamura T; Ohnishi H; Sakurama T
    J Bone Miner Res; 1995 Jun; 10(6):921-31. PubMed ID: 7572316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats.
    Tanaka Y; Nakamura T; Nishida S; Suzuki K; Takeda S; Sato K; Nishii Y
    J Bone Miner Res; 1996 Mar; 11(3):325-36. PubMed ID: 8852943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
    Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
    J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
    Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
    J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate.
    Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T
    J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.
    Rossini M; Gatti D; Zamberlan N; Braga V; Dorizzi R; Adami S
    J Bone Miner Res; 1994 Nov; 9(11):1833-7. PubMed ID: 7863833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
    Murakami H; Nakamura T; Tsurukami H; Abe M; Barbier A; Suzuki K
    J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
    Saino H; Matsuyama T; Takada J; Kaku T; Ishii S
    J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bone loss by bisphosphonate YM175 in ovariectomized dogs with dietary calcium restriction.
    Motoie H; Kanoh H; Ogata S; Kawamuki K; Shikama H; Fujikura T
    Jpn J Pharmacol; 1996 Jul; 71(3):239-46. PubMed ID: 8854206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
    Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
    J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.